BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,883,901 | -2.8% | 76,286,000 | 0.0% | 2.06% | -4.4% |
| Q2 2023 | $77,072,118 | -3.7% | 76,286,000 | -0.1% | 2.16% | -2.0% |
| Q1 2023 | $80,060,298 | -3.7% | 76,393,000 | -0.8% | 2.20% | +3.6% |
| Q4 2022 | $83,172,605 | +8.2% | 77,043,000 | 0.0% | 2.12% | +9.2% |
| Q3 2022 | $76,896,000 | +0.1% | 77,043,000 | +0.2% | 1.94% | +4.3% |
| Q2 2022 | $76,828,000 | -0.7% | 76,920,000 | 0.0% | 1.86% | +174.1% |
| Q1 2022 | $77,403,000 | +24.1% | 76,920,000 | +29.3% | 0.68% | +31.3% |
| Q4 2021 | $62,365,000 | +69.9% | 59,503,000 | +63.0% | 0.52% | +49.7% |
| Q3 2021 | $36,713,000 | +48.8% | 36,500,000 | +49.0% | 0.35% | +49.1% |
| Q2 2021 | $24,670,000 | – | 24,500,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |